Detalhe da pesquisa
1.
The unfavorable effects of COVID-19 on Dutch advanced melanoma care.
Int J Cancer
; 150(5): 816-824, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34605003
2.
Real-world outcomes of advanced melanoma patients not represented in phase III trials.
Int J Cancer
; 147(12): 3461-3470, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32559817
3.
Improving survival in advanced melanoma patients: a trend analysis from 2013 to 2021.
EClinicalMedicine
; 69: 102485, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38370537
4.
A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors.
Cancers (Basel)
; 15(11)2023 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37296885
5.
Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors.
Melanoma Res
; 32(6): 460-468, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35703270
6.
Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort study.
Eur J Cancer
; 167: 70-80, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35395553
7.
End-of-Life Use of Systemic Therapy in Patients With Advanced Melanoma: A Nationwide Cohort Study.
JCO Oncol Pract
; 18(10): e1611-e1620, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35944229
8.
Postapproval trials versus patient registries: comparability of advanced melanoma patients with brain metastases.
Melanoma Res
; 31(1): 58-66, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33351553
9.
Adjuvant treatment for melanoma in clinical practice - Trial versus reality.
Eur J Cancer
; 158: 234-245, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34600790